Cedric Davidsen

Dr. Cedric Davidsen

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Resuscitation
Verified
Journal Article
Closed access
CDCedric Davidsen
Cedric Davidsen
EPErik J.S. Packer
Erik J.S. Packer
KLKjetil H. Løland
Kjetil H. Løland
SRSvein Rotevatn
Svein Rotevatn
ENElse L. Nygreen
Else L. Nygreen
VTVegard Tuseth
Vegard Tuseth

1 September 2020 in Journal of Interventional Cardiology
Verified
Journal Article
Open access
CDCedric Davidsen
Cedric Davidsen
KBKirsten Bolstad
Kirsten Bolstad
ENEllisif Nygaard
Ellisif Nygaard
KVKjell Vikenes
Kjell Vikenes
SRSvein Rotevatn
Svein Rotevatn
VTVegard Tuseth
Vegard Tuseth
Background. Percutaneous coronary intervention exposes patient and staff to ionizing radiation. Although staff only receive a small fraction of patient dose through scatter radiation, there are concerns about the potential health effects of repeated exposure. Minimizing both patient and occupational exposure is needed. Objective. This article investigates patient and operator X-ray exposure over time in coronary intervention in relation to upgraded X-ray equipment, improved shielding, and enhanced operator awareness. Materials and Methods. Data regarding irradiation time, patient dose, and patient characteristics were extracted from the Norwegian Registry for Invasive Cardiology (NORIC) for procedures performed from 2013 to mid-2019. Personal operator dosimetry records were provided by the Norwegian Radiation and Nuclear Safety Authority. Improved operator shielding and awareness measures were introduced in 2018. Results. In the period 2013 through June 2019, 21499 procedures were recorded in our institution. Mean dose area product (DAP) for coronary angiography decreased 37% from 2981 μGy·m2 in 2013 to 1891 μGy·m2 in 2019 (p<0.001). For coronary intervention, DAP decreased 39% from 8358 μGy·m2 to 5055 μGy·m2. Personal dosimetry data indicate a 70% reduction in operator dose per procedure in 2019 compared to 2013. The most pronounced reduction occurred after improved radiation protection measures were implemented in 2018 (−48%). Conclusions. This study shows a temporal trend towards considerable reduction in X-ray doses received by the patient and operator during cardiac catheterization. Upgraded X-ray equipment, improved shielding, and enhanced operator awareness are likely contributors to this development.

1 December 2023 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Open access
CDCedric Davidsen
Cedric Davidsen
KYKristian Ytre-Hauge
Kristian Ytre-Hauge
ASAndreas Tefre Samnøy
Andreas Tefre Samnøy
KVKjell Vikenes
Kjell Vikenes
PLPatrizio Lancellotti
Patrizio Lancellotti
VTVegard Tuseth
Vegard Tuseth
BACKGROUND: Radiation shielding is mandatory during cardiac catheterization, but there is a need to improve efficacy and ease of use. METHODS: The aim of the study was to assess the shielding effect and user feedback for a novel flexible multiconfiguration x-ray shield (FMX). The 0.5-mm Pb equivalent FMX can be selectively configured to accommodate for variations in patient morphology, access site, and type of procedure with maintained visualization, vascular access, and shielding. To evaluate efficacy, relative operator dose (operator dose indexed for given dose) was measured during 103 consecutive procedures randomized in a 1:1 proportion to the current routine setup or FMX+routine. User feedback was collected on function, relevance, and likelihood of adoption into clinical practice. RESULTS: Median relative operator dose was 3.63 μSv/µGy·m 2 ×10 –3 (IQR, 2.62–6.37) with routine setup and 0.57 μSv/µGy·m 2 ×10 –3 (IQR, 0.27–1.06) with FMX+routine, which amounts to an 84.4% reduction ( P <0.001). For 500 procedures/year, this corresponds to an estimated yearly dose reduction from 3.6 to 0.7 mSv. User feedback regarding size, functionality, ease of use, likely to use, critical issues, shielding, draping, procedure time, vascular access, patient discomfort, and risk was 99% positive. No critical issues were identified. There was no significant difference in patient radiation exposure. CONCLUSIONS: The FMX reduces radiation exposure considerably. The FMX represents an effective and attractive solution for radiation protection that can easily be implemented in existing workflow. FMX has potential for general use with maintained visualization, vascular access, and shielding in routine cardiac catheterization.

19 May 2020 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
IKIman Karaji
Iman Karaji
ØBØyvind Bleie
Øyvind Bleie
KSKaia Skromme
Kaia Skromme
CDCedric Davidsen
Cedric Davidsen
A 74-year-old man was admitted with an acute deterioration after 14 days of dyspnoea and coughing. His electrocardiogram showed Q-waves and minor ST-elevation in inferior wall leads, suggestive of a myocardial infarction. He was transferred to our centre for coronary angiography, which displayed an occluded mid-right coronary artery and a proximal stenosis followed by a chronic total occlusion in the mid-left anterior descending artery. Transthoracic echocardiography revealed a large ventricular aneurysm in the basal inferior wall (Panel A and Supplementary data online, Moving Image A), with a small defect with bidirectional flow arising from the apical part of the aneurysm (Panels B and C, and Supplementary data online, Moving Image B).

10 November 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CDCedric Davidsen
Cedric Davidsen
KBKirsten Bolstad
Kirsten Bolstad
KYKristian Ytre-Hauge
Kristian Ytre-Hauge
ASAndreas Tefre Samnøy
Andreas Tefre Samnøy
KVKjell Vikenes
Kjell Vikenes
VTVegard Tuseth
Vegard Tuseth
Background: There is increasing concern and focus in the interventional cardiology community on potential long term health issues related to radiation exposure and heavy wearable protection. Optimized shielding measures may reduce operator dose to levels where lighter radioprotective garments can safely be used, or even omitted. X-ray blankets (XRB) are commercially available but suffer from small size and lack of stability. A larger XRB may reduce operator dose but could hamper vascular access and visualization. The aim of this study is to assess shielding effect of an optimized XRB during cardiac catheterization and estimate the potential reduction in annual operator dose based on DICOM Radiation Dose Structured Report (RDSR) data reflecting everyday clinical practice. Methods: Data accumulated from 7681 procedures over three years in our RDSR repository was used to identify projection angles and radiation doses during cardiac catheterization. Using an anthropomorphic phantom and a scatter radiation detector, radiation dose to the operator (mSv) and patient (dose area product—DAP) was measured for each angiographic projection for three different shielding setups. Relative operator dose (mSv/DAP) was calculated and multiplied by DAP per projection to estimate effect on operator dose. Results: Adding an optimized XRB to a standard shielding setup comprising a table- and ceiling-mounted shield resulted in a 94.9% reduction in estimated operator dose. The largest shielding effect was observed in left and cranial projections where the ceiling-mounted shield offered less protection. Conclusions: An optimized XRB is a simple shielding measure that has the potential to reduce operator dose.

26 April 2016 in Thrombosis Journal
Verified
Journal Article
Open access
PDF file
CDCedric Davidsen
Cedric Davidsen
TLTerje Hjalmar Larsen
Terje Hjalmar Larsen
EGEva Gerdts
Eva Gerdts
MLMai Tone Lønnebakken
Mai Tone Lønnebakken
In hereditary spherocytosis with severe anemia, splenectomy is a recommended treatment. However, the spleen carries an important role both in immune function and coagulation. The increased risk of bacterial infections associated with splenectomy is well known. Recently, hypercoagulation disorders have also been linked to splenectomy through loss of regulation of platelet activity, loss of filtering function and post-splenectomy thrombocytosis. A 28 year-old smoking women who had previously undergone splenectomy due to hereditary spherocytosis with a moderate thrombocytosis (platelet count 553–635*109/L), presented with recurrent episodes of pulmonary embolisms. Further examination by multimodality cardiac imaging demonstrated a giant chronic thrombus in the right ventricular outflow tract, which eventually had to be surgically removed. The present case highlights the increased risk of severe thromboembolic complications following therapeutic splenectomy in hereditary spherocytosis, and emphasis the important role of multimodality cardiac imaging in recurrent pulmonary embolism, diagnosing a giant chronic thrombus in the right ventricular outflow tract.